¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°¡¿Í»ç³¢º´ÇÐȸ Á¦14ȸ °¡¿Í»ç³¢º´ ½ÉÆ÷Áö¿ò : 2019-06-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°¡¿Í»ç³¢º´ÇÐȸ Á¦14ȸ °¡¿Í»ç³¢º´ ½ÉÆ÷Áö¿ò : 2019-06-01
±³À°ÀÏÀÚ : 2019-06-01
±³À°Àå¼Ò : °¡Åç·¢´ëÇб³ ¼ºÀDZ³Á¤ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£  
±³À°ÁÖÁ¦ : Á¦14ȸ °¡¿Í»ç³¢º´ ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇѼҾưúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°¡¿Í»ç³¢º´ÇÐȸ  
´ã´çÀÚ : ±è¼ºÇý
¿¬¶ôó : 02-3779-1206  
À̸ÞÀÏ : rohetkim@yahoo.co.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í Àü¹®ÀÇ / Àü°øÀÇ,ÀÇ·á±â»ç,°£È£»ç / Çлý ´çÀϵî·Ïºñ: 70,000 / 30,000 / ¹«·á »çÀüµî·Ïºñ: 60,000 / 20,000 / ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 09:00~09:15 The results of 2015-17 Nationwide survey of Kawasaki disease in Korea  ±è±â¹ü(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 09:15~09:30 Genetics: the role of B cell immunity in Kawasaki disease  ÀÌÁ¾±Ø(¾Æ»ê»ý¸í°úÇבּ¸¼Ò) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 09:30~09:45 A review of recent microRNA researches of Kawasaki disease  À±½Å¿ø(Á߾Ӵ뺴¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 09:45~10:00 Epigenetics on Kawasaki disease  Á¤´ëö(¼­¿ï¼º¸ðº´¿ø) 
Åä·Ð 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 10:00~10:15 ÁöÁ¤Åä·Ð  ½ÅÀºÁ¤,À±°æ¸²,À̼ö¿µ,ÀüÇö¿Á(ÀÎÇϴ뺴¿ø,°­µ¿°æÈñ´ëº´¿ø,ºÎõ¼º¸ðº´¿ø,°­¸ª¾Æ»êº´¿ø) 
È޽Ġ06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 10:15~10:40 Coffee break  () 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 10:40~11:30 ±¸¿¬ ¹ßÇ¥  ±è¼ºÈ£,ÀÌÇØ¿ë(ºÎõ¼¼Á¾º´¿ø,¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 11:30~12:00 ¡°°¡¿Í»ç³¢º´°ú ÇÔ²² ÇÑ 40³â¡±  ÀÌ°æÀÏ(°¡Å縯´ëÇб³ ´ëÀü¼º¸ðº´¿ø) 
½Ä»ç 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 12:00~13:00 Á¡½É ½Ä»ç  () 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 13:00~13:10 Characteristics of Kawasaki disease manifested by abdominal symptoms  À±ÀÚ°æ(ºÎõ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 13:10~13:20 Kawasaki disease with lymphadenopathy first presentation  ¼ÕÀ缺(°Ç±¹´ëº´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 13:20~13:30 Vital signs as predictor of IVIG resistance in children with Kawasaki disease  ÃµÀºÁ¤(°Ç¾ç´ëº´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 13:30~13:40 Is Harada score still the best predictor of coronary artery aneurysm?  Çϱâ¼ö(°í´ë±¸·Îº´¿ø) 
Åä·Ð 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 13:40~14:00 ÁöÁ¤Åä·Ð  °íÈÆ,°ûÁöÈñ,±è¼ºÈÆ,ÃÖÈñÁ¤(ºÎ»ê´ëº´¿ø,°­ºÏ»ï¼ºº´¿ø,â¿ø»ï¼ºº´¿ø,°è¸í´ëµ¿»êÀÇ·á¿ø) 
È޽Ġ06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 14:00~14:20 Coffee break  () 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 14:20~15:10 Áõ·Ê ¹ßÇ¥  ±æÈ«·®,±è¿ë¿í(Ãæ³²´ëº´¿ø,±¤Áֱ⵶º´¿ø) 
È޽Ġ06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 15:10~15:30 Coffee break  () 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 15:30~15:40 Italian guidelines and European recommendations of management of patients with Kawasaki disease  ±è¼ºÇý(ÇѸ²´ë¼º½Éº´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 15:40~15:50 Echocardiographic functional studies during the acute phase of Kawasaki disease  °­¼öÁ¤(ºÐ´çÂ÷º´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 16:00~16:10 Clinical usefulness of NT-proBNP/BNP and Procalcitonin  Çѹ̿µ(°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 16:10~16:20 Use of new drugs – statins, Anakinra, others (ARB, doxycycline, etc)  Á¤¼öÀÎ(¾ÆÁִ뺴¿ø) 
Åä·Ð 06-01 ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 1003È£ 16:20~16:30 ÁöÁ¤Åä·Ð  ¾È°æÁø,À±ÁöÈ«,À̼±Çâ,Á¤¼¼¿ë(±æº´¿ø,¼­¿ï¼º¸ðº´¿ø,¼øõÇâ´ëºÎõº´¿ø,½ÅÃ̼¼ºê¶õ½ºº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°¡¿Í»ç³¢º´ÇÐȸ Á¦14ȸ °¡¿Í»ç³¢º´ ½ÉÆ÷Áö¿ò : 2019-06-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç±¹´ëÇб³º´¿ø ´ëÇÑÀÇÁø±ÕÇÐȸ Á¦26Â÷ Çмú´ëȸ ÇÁ·Î±×·¥ : 2019-06-01
´ÙÀ½±Û Á¦38Â÷ ´ëÇѼöÇ÷ÇÐȸ Çмú´ëȸ : 2019-06-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 5 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 0 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 0 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 0 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 2 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 0 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 1 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷